4.7 Article

Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic

Pooja Ojha et al.

Summary: Olfactory dysfunction is a recognized symptom of SARS-CoV-2 and is associated with neurodegenerative disorders. This article reviews the literature on olfactory training as a treatment for olfactory dysfunction during COVID-19. The findings suggest that olfactory training is effective in curbing the progression of olfactory dysfunction and does not have significant adverse effects.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)

Article Otorhinolaryngology

What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?

Clair Vandersteen et al.

Summary: The study showed that SST-12 is a quick and reliable tool for screening post-COVID-19 olfactory impaired patients on a large scale and can be used in daily clinical practice.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Otorhinolaryngology

Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up

Luigi Angelo Vaira et al.

Summary: This study evaluated olfactory dysfunction in patients after COVID-19 and found that the prevalence of OD was significantly higher in the COVID-19 group compared to the control group, indicating that this result was not affected by the baseline prevalence of OD in the general population.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Letter Otorhinolaryngology

Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study

Fabio Ferreli et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Otorhinolaryngology

Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study

Paolo Boscolo-Rizzo et al.

Summary: The study aimed to estimate the 1-year prevalence and recovery rate of self-reported chemosensory dysfunction in patients with previous mild-to-moderate symptomatic COVID-19. The findings showed that 21.3% of patients still reported chemosensory dysfunction 1 year after onset, with 69.5% experiencing complete resolution, 21.9% reporting decreased severity, and 8.6% reporting unchanged or worse symptoms. Patients with higher baseline SNOT-22 scores and longer duration for a negative swab had a higher risk of persistence of symptoms.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Review Otorhinolaryngology

Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis

Nrusheel Kattar et al.

Summary: Meta-analysis of existing data confirms clinically significant improvements in PVOD associated with OT. There is variability among OT protocols that may benefit from further optimization. Existing data supports the use of OT for the treatment of existing and newly emerging cases of PVOD.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Article Clinical Neurology

The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning

Gabriel A. de Erausquin et al.

Summary: The impact of SARS-CoV-2 on the central nervous system has raised concerns about the risk of later life cognitive decline, Alzheimer's disease, and other dementia. An international consortium has been formed to study the short and long-term consequences of the virus on the CNS and enroll individuals for evaluations to better understand the underlying biology contributing to AD and dementia.

ALZHEIMERS & DEMENTIA (2021)

Review Psychiatry

Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?

Lindsay S. McAlpine et al.

Summary: Patients with neurodegenerative diseases, such as dementia, Parkinson's disease, and multiple sclerosis, are at higher risk of being hospitalized due to COVID-19. The virus could potentially accelerate neurodegeneration in vulnerable individuals. It is important to implement additional precautions and optimize management for these patients to prevent severe outcomes.

CURRENT OPINION IN PSYCHIATRY (2021)

Article Otorhinolaryngology

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

Serge-Daniel Le Bon et al.

Summary: This pilot study suggests that the combination of a short course of oral corticosteroids and olfactory training is safe and beneficial in helping patients with enduring dysosmia recover from olfactory loss due to COVID-19. Larger cohorts are needed to further investigate and confirm these findings.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Medicine, General & Internal

Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients

J. R. Lechien et al.

Summary: This study found that olfactory dysfunction (OD) is more prevalent in mild cases of COVID-19 compared to moderate-to-critical forms. Additionally, 24.1% of patients did not subjectively recover olfaction 60 days after the onset of the dysfunction. Objective olfactory evaluations identified hyposmia/anosmia in a significant percentage of patients, with higher baseline severity of objective olfactory evaluations strongly predictive of persistent OD.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Medicine, Research & Experimental

COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste

Andreas Steenholt Niklassen et al.

Summary: Chemosensory dysfunction is common in COVID-19, with significant differences in olfactory function during and after infection. Most patients recover within the first 28 days, but some may experience persistent dysfunction and should seek specialist care.

LARYNGOSCOPE (2021)

Article Otorhinolaryngology

Six month follow-up of self-reported loss of smell during the COVID-19 pandemic

Claire Hopkins et al.

Summary: This study investigated the recovery of loss of smell and prevalence of parosmia in COVID-19 patients. Some patients continued to experience ongoing symptoms, such as fatigue, at 6 months. The prevalence of parosmia remained high even in patients who reported some recovery of olfactory function.

RHINOLOGY (2021)

Review Physiology

COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology

Nicolas Meunier et al.

Summary: Smell and taste impairments are common symptoms in COVID-19 patients, with the virus affecting the neuroanatomical pathways and central nervous system involved in these senses, impacting the physiology and dietary management of patients.

FRONTIERS IN PHYSIOLOGY (2021)

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Review Multidisciplinary Sciences

Olfactory recovery following infection with COVID-19: A systematic review

Ali Jafar et al.

Summary: Loss of smell is a common symptom associated with COVID-19 infection, with most patients recovering their sense of smell within 30 days. Patients with severe initial olfactory loss have lower recovery rates. Additional trials on olfactory retraining and steroid therapy are ongoing.

PLOS ONE (2021)

Editorial Material Otorhinolaryngology

Patient-reported olfactory recovery after SARS-CoV-2 infection: A 6-month follow-up study

Daniela Lucidi et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)

Article Biochemistry & Molecular Biology

Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection

Maria Isabella Donegani et al.

Summary: This study identified cortical hypometabolism in patients with isolated persistent hyposmia after SARS-CoV2 infection using [F-18]-FDG PET, and highlighted the involvement of bilateral longitudinal fasciculi in the structural connectivity of these regions.

BIOMEDICINES (2021)

Article Otorhinolaryngology

Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers

Juan Riestra-Ayora et al.

Summary: In COVID-19 patients, olfactory and gustatory dysfunction showed high-resolution rates within the first two months after onset, but 11% did not fully recover and 30% partially recovered after 6 months. There was a high correlation between olfactory and gustatory dysfunction, while nasal obstruction and dyspnea were identified as risk factors for symptom persistence.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Otorhinolaryngology

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M. Petrocelli et al.

Summary: A study found that six months after the onset of COVID-19, about 6% of patients still had severe persistent olfactory or gustatory disturbances.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Article Cell Biology

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters

Guilherme Dias de Melo et al.

Summary: Recent investigations have shown that olfactory and taste dysfunction are common in mildly symptomatic COVID-19 patients. Research on the olfactory neuroepithelium revealed that SARS-CoV-2 infection can cause local inflammation and lead to acute loss of smell, which may account for prolonged symptoms of COVID-19 such as anosmia.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Otorhinolaryngology

Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS)

Celine Leclercq et al.

Summary: The study developed a French Short Version of the Questionnaire of Olfactory Disorders, Fr-sQOD, to assess the quality of life impairments of patients with olfactory dysfunction. The Fr-sQOD showed high internal consistency, test-retest reliability, and acceptable external validity, making it a reliable and valid tool for evaluating the impact of OD on the quality of life of French-speaking patients.

ENT-EAR NOSE & THROAT JOURNAL (2021)

Article Microbiology

Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study

Sven Saussez et al.

Summary: The early use of oral corticosteroids or nasal corticosteroids in combination with olfactory training seems to have better efficacy in improving COVID-19 related olfactory dysfunction compared to olfactory training alone, but the long-term outcomes remain uncertain, requiring further research to validate.

PATHOGENS (2021)

Review Medicine, General & Internal

Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction

Katie E. Webster et al.

Summary: Loss of olfactory function is a common symptom of COVID-19 infection, and it is not clear whether early intervention with any form of treatment can promote recovery and prevent persisting olfactory disturbance. Only limited evidence is available regarding the efficacy of different interventions to prevent persistent olfactory dysfunction following COVID-19 infection.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Letter Radiology, Nuclear Medicine & Medical Imaging

18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19

Mahboobeh Karimi-Galougahi et al.

ACADEMIC RADIOLOGY (2020)

Article Otorhinolaryngology

Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study

Claire Hopkins et al.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Article Otorhinolaryngology

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Editorial Material Clinical Neurology

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Michael T. Heneka et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Article Medicine, General & Internal

Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study

Yiping Lu et al.

ECLINICALMEDICINE (2020)

Article Otorhinolaryngology

The Impact of Olfactory Dysfunction on the Psychological Status and Quality of Life of Patients with Nasal Obstruction and Septal Deviation

Konstantinos Valsamidis et al.

INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY (2020)

Article Otorhinolaryngology

Advances in Understanding Parosmia: An fMRI Study

Emilia Iannilli et al.

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY (2019)

Article Otorhinolaryngology

A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis

Jose L. Mattos et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2019)

Article Otorhinolaryngology

Updated Sniffin' Sticks normative data based on an extended sample of 9139 subjects

A. Oleszkiewicz et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2019)

Article Medicine, Research & Experimental

Examination of Olfactory Training Effectiveness in Relation to Its Complexity and the Cause of Olfactory Loss

Anna Oleszkiewicz et al.

LARYNGOSCOPE (2018)

Article Otorhinolaryngology

Effects of olfactory training: a meta-analysis

RHINOLOGY (2018)

Article Otorhinolaryngology

Association of Alterations in Smell and Taste with Depression in Older Adults

Kevin Hur et al.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2018)

Article Neuroimaging

Changes in olfactory bulb volume following lateralized olfactory training

S. Negoias et al.

BRAIN IMAGING AND BEHAVIOR (2017)

Article Behavioral Sciences

Olfactory Disorders and Quality of Life-An Updated Review

Ilona Croy et al.

CHEMICAL SENSES (2014)

Article Otorhinolaryngology

Risk Factors for Hazardous Events in Olfactory-Impaired Patients

Taylor S. Pence et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)

Article Neurosciences

Recovery of Olfactory Function Induces Neuroplasticity Effects in Patients with Smell Loss

Kathrin Kollndorfer et al.

NEURAL PLASTICITY (2014)

Article Neurosciences

GRAY MATTER ALTERATIONS IN PAROSMIA

T. Bitter et al.

NEUROSCIENCE (2011)

Article Psychology, Clinical

Cognitive factors in odor detection, odor discrimination, and odor identification tasks

Margareta Hedner et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)

Article Medicine, Research & Experimental

Effects of Olfactory Training in Patients with Olfactory Loss

Thomas Hummel et al.

LARYNGOSCOPE (2009)

Article Psychology, Clinical

Sense of Smell Disorder and Health-Related Quality of Life

Monique A. M. Smeets et al.

REHABILITATION PSYCHOLOGY (2009)

Article Medicine, Research & Experimental

The Influence of Olfactory Loss on Dietary Behaviors

Katja Aschenbrenner et al.

LARYNGOSCOPE (2008)

Article Neurosciences

An olfacto-hippocampal network is dynamically involved in odor-discrimination learning

Claire Martin et al.

JOURNAL OF NEUROPHYSIOLOGY (2007)